Search

Author/Creator Stumpp, Michael T.

1. Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. Issue 8 (17th November 2017)

Authors:
Binz, H. Kaspar; Bakker, Talitha R.; Phillips, Douglas J.; Cornelius, Andreas; Zitt, Christof; Göttler, Thomas; Sigrist, Gabriel; Fiedler, Ulrike; Ekawardhani, Savira; Dolado, Ignacio; Saliba, Johan Abram; Tresch, Gaby; Proba, Karl; Stumpp, Michael T.
Journal:
MAbs
Issue:
Volume 9:Issue 8(2017)
Page Start:
1262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First-in-Human Phase I Study of MP0250, a First-in-Class DARPin Drug Candidate Targeting VEGF and HGF, in Patients With Advanced Solid Tumors. Issue 2 (10th January 2021)

Authors:
Baird, Richard D.; Linossi, Constanza; Middleton, Mark; Lord, Simon; Harris, Adrian; Rodón, Jordi; Zitt, Christof; Fiedler, Ulrike; Dawson, Keith M.; Leupin, Nicolas; Stumpp, Michael T.; Harstrick, Andreas; Azaro, Analía; Fischer, Stefanie; Omlin, Aurelius
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 2(2021)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search